デフォルト表紙
市場調査レポート
商品コード
1446548

皮膚科用イメージングデバイスの市場規模、シェア、動向分析レポート:モダリティ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Digital Photographic Imaging, OCT, Dermatoscope, High Frequency Ultrasound), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 195 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
皮膚科用イメージングデバイスの市場規模、シェア、動向分析レポート:モダリティ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年02月23日
発行: Grand View Research
ページ情報: 英文 195 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮膚科用イメージングデバイス市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、皮膚科用イメージングデバイスの世界市場規模は2030年までに56億米ドルに達すると予測され、2024年から2030年までのCAGRは13.09%で成長すると予測されています。

がんや炎症性皮膚疾患などの皮膚疾患の有病率の増加が市場成長の主な要因です。例えば、国際がん研究機関によると、2022年には世界で331,722例のメラノーマがんが報告され、さらに2027年には1,262,756例に達すると推定されています。さらに、技術の進歩も市場の成長を促進すると予想されています。

皮膚科用イメージングデバイスは、皮膚病変やその他の関連症状を非侵襲的かつ高解像度で可視化できるため、効率的です。多様な皮膚異常の詳細な形態、構造、特徴を提供することで皮膚科医を支援し、正確な診断と治療戦略の立案に役立ちます。さらに、遠隔診療を可能にし、専門医が画像や専門知識を交換できるようにすることで、患者の治療を向上させる。

高解像度画像、AIとの統合、3Dイメージングなど、皮膚科用イメージングデバイスの技術的進歩はさらに市場成長に寄与すると期待されています。例えば、2023年6月、皮膚科向け医用イメージングシステムの著名なメーカーであるFotoFinder Systems GmbHは、最近、2つの新しい最先端のイノベーションを発表した-美容用のポータブル画像ソリューションであるmeesmaと、全身皮膚鏡検査用のAIMEEと呼ばれるAIアシスタントを搭載した第4世代のFotoFinder ATBM masterです。これらの最先端システムは、2023年7月3日から8日までシンガポールで開催される「第25回世界皮膚科学会」(WCD)で初めて専門家に公開されます。

市場参入企業は競争力を維持し市場シェアを拡大するため、さまざまな戦略的取り組みを実施しています。こうした取り組みには、製品の上市、政府認可、事業拡大、提携、合併、買収などが含まれます。2023年5月、Orlucentの皮膚蛍光イメージングシステムが米国食品医薬品局(FDA)からブレークスルーデバイス指定(BDD)を取得しました。この革新的なツールは、成人の異常なほくろの発生に関連する生物学的組織改造活動を、侵襲的な処置を必要とすることなく同定・評価することができます。

皮膚科用イメージングデバイス市場レポート・ハイライト

  • モダリティ別では、ダーモスコープセグメントが2023年に41.42%の最大収益シェアで市場をリード、また、デジタル写真イメージングセグメントは予測期間中に最も速いCAGRで成長すると予測されます。
  • 用途別では、皮膚がんセグメントが2023年に48.63%の最大収益シェアで市場を占めました。一方、形成外科・再建手術セグメントは予測期間中に最も速いCAGRで成長すると予測されています。
  • 最終用途別では、病院が2023年に43.99%の最大収益シェアで市場を占めました。また、皮膚科センターセグメントは予測期間中に最も速いCAGRで成長すると予測されています。
  • 北米は2023年に39.48%の収益シェアで市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 皮膚科用イメージングデバイス市場:変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
  • 皮膚科用イメージングデバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 皮膚科用イメージングデバイス市場:モダリティの推定・動向分析

  • モダリティの市場シェア、2023年と2030年
  • セグメントダッシュボード
  • モダリティ別の世界の皮膚科用イメージングデバイス市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
  • デジタル写真イメージング
  • OCT
  • ダーモスコープ
  • 高周波超音波
  • その他

第5章 皮膚科用イメージングデバイス市場:用途の推定・動向分析

  • 用途の市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 用途別の世界の皮膚科用イメージングデバイス市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
  • 皮膚がん
  • 炎症性皮膚炎
  • 形成外科・再建手術
  • その他

第6章 皮膚科用イメージングデバイス市場:最終用途の推定・動向分析

  • 最終用途の市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界の皮膚科用イメージングデバイス市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
  • 病院
  • 皮膚科センター
  • 専門クリニック

第7章 皮膚科用イメージングデバイス市場:地域の推定・動向分析、国別、モダリティ別、用途別、最終用途別

  • 地域の市場ダッシュボード
  • 世界の地域の市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年まで
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • 主要企業の市場シェア分析、2023年
  • 企業ポジション分析、2023年
  • 企業の分類(新興企業、革新者、リーダー)
  • 企業プロファイル
    • Canfield Scientific, Inc.
    • FotoFinder Systems GmbH
    • e-con Systems Inc.
    • Courage+Khazaka electronic GmbH
    • Longport, Inc.
    • Cortex Technology
    • DRAMINSKI SA
    • GE HealthCare
    • VisualSonics
    • Clarius
    • Koninklijke Philips NV
    • Michelson Diagnostics Ltd(MDL)
    • Caliber Imaging and Diagnosis
    • DermLite
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America dermatology imaging devices market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 5 North America dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 6 North America dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 8 U.S. dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 9 U.S. dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 10 Canada dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 11 Canada dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 12 Canada dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 13 Europe dermatology imaging devices market, By country, 2018 - 2030 (USD Million)
  • Table 14 Europe dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 15 Europe dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 16 Europe dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 17 UK dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 18 UK dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 19 UK dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 20 Germany dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 21 Germany dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 22 Germany dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 23 France dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 24 France dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 25 France dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 26 Italy dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 27 Italy dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 28 Italy dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 29 Denmark dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 30 Denmark dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 31 Denmark dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 32 Sweden dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 33 Sweden dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 34 Sweden dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 35 Norway dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 36 Norway dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 37 Norway dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific dermatology imaging devices market, By country, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 42 Japan dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 43 Japan dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 44 Japan dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 45 China dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 46 China dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 47 China dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 48 India dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 49 India dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 50 India dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 51 Australia dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 52 Australia dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 53 Australia dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 54 South Korea dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 55 South Korea dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 56 South Korea dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 57 Thailand dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 58 Thailand dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 59 Thailand dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 60 Latin America dermatology imaging devices market, By Country, 2018 - 2030 (USD Million)
  • Table 61 Latin America dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 62 Latin America dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 63 Latin America dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 64 Brazil dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 65 Brazil dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 66 Brazil dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 67 Mexico dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 68 Mexico dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 69 Mexico dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 70 Argentina dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 71 Argentina dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 72 Argentina dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa dermatology imaging devices market, By country, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 77 South Africa dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 78 South Africa dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 79 South Africa dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 83 UAE dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 84 UAE dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 85 UAE dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)
  • Table 86 Kuwait dermatology imaging devices market, By modality, 2018 - 2030 (USD Million)
  • Table 87 Kuwait dermatology imaging devices market, By application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait dermatology imaging devices market, By end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Dermatology imaging devices market: Market outlook
  • Fig. 14 Dermatology imaging devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Dermatology imaging devices market driver impact
  • Fig. 20 Dermatology imaging devices market restraint impact
  • Fig. 21 Dermatology imaging devices market: modality movement analysis
  • Fig. 22 Dermatology imaging devices market: modality outlook and key takeaways
  • Fig. 23 Digital photographic imaging market estimates and forecast, 2018 - 2030
  • Fig. 24 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
  • Fig. 25 Dermatoscope market estimates and forecast, 2018 - 2030
  • Fig. 26 High frequency ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 27 Others market estimates and forecast, 2018 - 2030
  • Fig. 28 Dermatology imaging devices market: application movement analysis
  • Fig. 29 Dermatology imaging devices market: application outlook and key takeaways
  • Fig. 30 Skin cancers market estimates and forecast, 2018 - 2030
  • Fig. 31 Inflammatory dermatoses market estimates and forecast, 2018 - 2030
  • Fig. 32 Skin psoriasis dermatoses market estimates and forecast, 2018 - 2030
  • Fig. 33 Eczema (Atopic dermatitis) dermatoses market estimates and forecast, 2018 - 2030
  • Fig. 34 Others dermatoses market estimates and forecast, 2018 - 2030
  • Fig. 35 Plastic and reconstructive surgery market estimates and forecast, 2018 - 2030
  • Fig. 36 Others market estimates and forecast, 2018 - 2030
  • Fig. 37 Dermatology imaging devices market: end-use movement analysis
  • Fig. 38 Dermatology imaging devices market: end-use outlook and key takeaways
  • Fig. 39 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 40 Dermatology Centers market estimates and forecast, 2018 - 2030
  • Fig. 41 Specialty clinics market estimates and forecast, 2018 - 2030
  • Fig. 42 Global Dermatology Imaging Devices market: Regional Movement Analysis
  • Fig. 43 Global Dermatology imaging devices market: regional outlook and key takeaways
  • Fig. 44 North America
  • Fig. 45 North America market estimates and forecast, 2018 - 2030
  • Fig. 46 U.S.
  • Fig. 47 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 48 Canada
  • Fig. 49 Canada market estimates and forecast, 2018 - 2030
  • Fig. 50 Europe
  • Fig. 51 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 52 UK
  • Fig. 53 UK market estimates and forecast, 2018 - 2030
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecast, 2018 - 2030
  • Fig. 56 France
  • Fig. 57 France market estimates and forecast, 2018 - 2030
  • Fig. 58 Italy
  • Fig. 59 Italy market estimates and forecast, 2018 - 2030
  • Fig. 60 Spain
  • Fig. 61 Spain market estimates and forecast, 2018 - 2030
  • Fig. 62 Denmark
  • Fig. 63 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 64 Sweden
  • Fig. 65 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 66 Norway
  • Fig. 67 Norway market estimates and forecast, 2018 - 2030
  • Fig. 68 Asia Pacific
  • Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 70 Japan
  • Fig. 71 Japan market estimates and forecast, 2018 - 2030
  • Fig. 72 China
  • Fig. 73 China market estimates and forecast, 2018 - 2030
  • Fig. 74 India
  • Fig. 75 India market estimates and forecast, 2018 - 2030
  • Fig. 76 South Korea
  • Fig. 77 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 78 Thailand
  • Fig. 79 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 80 Australia
  • Fig. 81 Australia market estimates and forecast, 2018 - 2030
  • Fig. 82 Latin America
  • Fig. 83 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 84 Brazil
  • Fig. 85 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 86 Mexico
  • Fig. 87 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 88 Argentina
  • Fig. 89 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 90 Middle East and Africa
  • Fig. 91 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 92 Saudi Arabia
  • Fig. 93 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 94 South Africa
  • Fig. 95 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 96 UAE
  • Fig. 97 UAE market estimates and forecast, 2018 - 2030
  • Fig. 98 Kuwait
  • Fig. 99 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 100 Participant categorization- Dermatology imaging devices market
  • Fig. 101 Market share of key market players- Dermatology imaging devices market
目次
Product Code: GVR-4-68040-199-1

Dermatology Imagine Devices Market Growth & Trends:

The global dermatology imaging devices market size is anticipated to reach USD 5.60 billion by 2030 and it is projected to grow at a CAGR of 13.09% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of skin disorders such as cancer, and inflammatory dermatoses, among others are the major contributing factors for market growth. For instance, according to the International Agency for Research on Cancer, in 2022, globally 331, 722 cases of melanoma cancer were reported, the cases are further estimated to reach 1,262,756 by 2027. Furthermore, technological advancements are also expected to propel market growth.

Dermatology imaging devices are efficient as they provide non-invasive, high-resolution visualization of skin lesions and other related conditions. They help dermatologists by providing detailed morphology, structure, and traits of diverse skin abnormalities, which thereby help in precise diagnosis and treatment strategizing. Moreover, they enable remote consultation, assist specialists to exchange images and expertise, thereby enhancing patient care.

Technological advancements in dermatology imaging devices such as high-resolution images, integration with AI, 3D imaging are further expected to contribute to the market growth. For instance, ,in June 2023, FotoFinder Systems GmbH, a prominent manufacturer of medical imaging systems for dermatology, has recently unveiled two new cutting-edge innovations - the meesma, a portable imaging solution for aesthetics, and the fourth generation FotoFinder ATBM master equipped with an AI assistant called AIMEE for Total Body Dermoscopy. These state-of-the-art systems are showcased for the first time to experts at the "25th World Congress of Dermatology" (WCD) in Singapore, scheduled from 3rd to 8th July 2023.

Market participants are implementing a range of strategic initiatives to maintain competitiveness and expand their market share. These initiatives include product launch, government approval, expansion, partnership, merger, and acquisitions. In May 2023,Orlucent's skin fluorescence imaging system has been granted Breakthrough Device Designation (BDD) by the US Food and Drug Administration (FDA).t's a handheld point-of-care device that provides molecular-level imaging and analysis of moles. This innovative tool can identify and assess biological tissue-remodeling activity associated with the development of abnormal moles in adults, all without requiring invasive procedures.

Dermatology Imaging Devices Market Report Highlights:

  • Based on modality, the dermatoscope segment led the market with the largest revenue share of 41.42% in 2023, Also, the digital photographic imaging segment is anticipated to grow at the fastest CAGR during the forecast period
  • Based on application, the skin cancer segment held the market with the largest revenue share of 48.63% in 2023. On other hand, the plastic and reconstructive surgery segment is expected to grow at the fastest CAGR during the forecast period
  • Based on end-use, the hospitals held the market with the largest revenue share of 43.99% in 2023. And, the dermatology centers segment is expected to grow at a fastest CAGR over the forecast period.
  • North America dominated the market with the revenue share of 39.48% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Dermatology Imaging Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of skin disorders and skin cancers
      • 3.2.1.2. Growing awareness for the early disease diagnosis
      • 3.2.1.3. Rising demand for non-invasive diagnostic procedures
      • 3.2.1.4. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness about the benefits of dermatology imaging
      • 3.2.2.2. High cost of dermatology imaging devices
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing demand for portable and handheld imaging devices
      • 3.2.3.2. Growing healthcare expenditure in emerging economies
  • 3.3. Dermatology Imaging Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Dermatology Imaging Devices Market: Modality Estimates & Trend Analysis

  • 4.1. Modality Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Dermatology Imaging Devices Market by Modality Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Digital Photographic Imaging
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Optical Coherence Tomography (OCT)
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Dermatoscope
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. High Frequency Ultrasound
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dermatology Imaging Devices Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Dermatology Imaging Devices Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Skin Cancers
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Inflammatory Dermatoses
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Skin psoriasis
      • 5.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Eczema (Atopic dermatitis)
      • 5.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Plastic and Reconstructive Surgery
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dermatology Imaging Devices Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Dermatology Imaging Devices Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Dermatology Centers
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Specialty Clinics
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dermatology Imaging Devices Market: Regional Estimates & Trend Analysis by Country, Modality, Application, and End Use

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Reimbursement structure
      • 7.4.1.4. Competitive scenario
      • 7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Reimbursement structure
      • 7.4.2.4. Competitive scenario
      • 7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Reimbursement structure
      • 7.5.1.4. Competitive scenario
      • 7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Reimbursement structure
      • 7.5.2.4. Competitive scenario
      • 7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Reimbursement structure
      • 7.5.3.4. Competitive scenario
      • 7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Reimbursement structure
      • 7.5.4.4. Competitive scenario
      • 7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Reimbursement structure
      • 7.5.5.4. Competitive scenario
      • 7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Reimbursement structure
      • 7.5.6.4. Competitive scenario
      • 7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Reimbursement structure
      • 7.5.7.4. Competitive scenario
      • 7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Reimbursement structure
      • 7.5.8.4. Competitive scenario
      • 7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Reimbursement structure
      • 7.6.1.4. Competitive scenario
      • 7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Reimbursement structure
      • 7.6.2.4. Competitive scenario
      • 7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Reimbursement structure
      • 7.6.3.4. Competitive scenario
      • 7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Reimbursement structure
      • 7.6.4.4. Competitive scenario
      • 7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Reimbursement structure
      • 7.6.5.4. Competitive scenario
      • 7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Reimbursement structure
      • 7.6.6.4. Competitive scenario
      • 7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Reimbursement structure
      • 7.7.1.4. Competitive scenario
      • 7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Mexico
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Reimbursement structure
      • 7.7.2.4. Competitive scenario
      • 7.7.2.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Reimbursement structure
      • 7.7.3.4. Competitive scenario
      • 7.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Reimbursement structure
      • 7.8.1.4. Competitive scenario
      • 7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Reimbursement structure
      • 7.8.2.4. Competitive scenario
      • 7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Reimbursement structure
      • 7.8.3.4. Competitive scenario
      • 7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Reimbursement structure
      • 7.8.4.4. Competitive scenario
      • 7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key Company Market Share Analysis, 2023
  • 8.4. Company Position Analysis, 2023
  • 8.5. Company Categorization (Emerging Players, Innovators, and Leaders)
  • 8.6. Company Profiles
    • 8.6.1. Canfield Scientific, Inc.
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. FotoFinder Systems GmbH
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. e-con Systems Inc.
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Courage+Khazaka electronic GmbH
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Longport, Inc.
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Cortex Technology
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. DRAMINSKI S. A.
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. GE HealthCare
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. VisualSonics
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. Clarius
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives
    • 8.6.11. Koninklijke Philips N.V.
      • 8.6.11.1. Company overview
      • 8.6.11.2. Financial performance
      • 8.6.11.3. Product benchmarking
      • 8.6.11.4. Strategic initiatives
    • 8.6.12. Michelson Diagnostics Ltd (MDL)
      • 8.6.12.1. Company overview
      • 8.6.12.2. Financial performance
      • 8.6.12.3. Product benchmarking
      • 8.6.12.4. Strategic initiatives
    • 8.6.13. Caliber Imaging and Diagnosis
      • 8.6.13.1. Company overview
      • 8.6.13.2. Financial performance
      • 8.6.13.3. Product benchmarking
      • 8.6.13.4. Strategic initiatives
    • 8.6.14. DermLite
      • 8.6.14.1. Company overview
      • 8.6.14.2. Financial performance
      • 8.6.14.3. Product benchmarking
      • 8.6.14.4. Strategic initiatives